Pressroom: Media Coverage

Showing 361 - 380 of 727 news items


Taking a Supplement? Tell Your Doctor

Integrative Medicine Service Chief Barrie Cassileth commented on the importance of informing your doctor of all medicines you take, including supplements.

April 8, 2013
MEK: A Single Drug Target Shows Promise in Multiple Cancers

Endocrinologist James Fagin spoke about a study he led that found that an investigational drug may help some patients with thyroid cancer who are unable to absorb radioactive iodine, the most effective therapy for the disease.

April 5, 2013
World-Class Cancer Treatment, Closer to Home

Victor Ribaudo, Executive Director of Memorial Sloan Kettering’s Regional Care Network, spoke about plans to open a new suburban outpatient treatment center in Middletown, New Jersey.

April 2, 2013
The New Breast Rating You Need to Know

Surgical oncologist Monica Morrow explained how breast density affects cancer risk.

April 1, 2013
Robin Roberts: "I'm Stronger Than I Thought I Was"

Hematologist-oncologist Sergio Giralt was interviewed about treating Good Morning America co-host Robin Roberts, who received a stem cell transplant at Memorial Sloan Kettering.

March 31, 2013
When a Famous Hospital Didn't Want an Expensive New Drug

Medical oncologist Leonard Saltz and epidemiologist Peter Bach commented on Memorial Sloan Kettering’s decision not to carry a new colorectal cancer drug due to its cost.

March 28, 2013
Skin Care for Cancer Patients

Dermatologist Mario Lacouture was interviewed about the effects of chemotherapy on the skin.

March 25, 2013
Surgery Restoring Penis after Prostate Cancer Increasing

Director of Memorial Sloan Kettering’s Male Sexual and Reproductive Medicine Program John Mulhall discussed ways to improve sexual function after prostate cancer surgery.

March 25, 2013
Little Support for Idea of Medicare Payments That Vary

Epidemiologist Peter Bach commented on a report he coauthored that argues that Medicare payments should not be adjusted on a regional basis.

March 23, 2013
Can Research "Dream Teams" Find the Cure for Cancer?

Medical oncologist Larry Norton discussed cancer advances made possible by collaborative efforts like those described in a recent TIME magazine article.

March 21, 2013
Experimental Cancer Treatment Offers Hope

Medical oncologist Renier Brentjens was interviewed about a study he co-led with cell researcher Michel Sadelain that found that genetically modified immune cells were able to induce complete remissions in patients with advanced B cell acute lymphoblastic leukemia.

March 21, 2013
Cell Therapy Shows Promise for Acute Type of Leukemia

Medical oncologist Renier Brentjens and cell researcher Michel Sadelain reported for the first time that genetically modified immune cells were able to induce complete remissions in all five patients treated with the experimental therapy. Patients had advanced B cell acute lymphoblastic leukemia, a disease with limited treatment options.

March 21, 2013
New Medical Technology Draws on Nature for Inspiration

Medical oncologist Howard Scher commented on an investigational microchip that can count and sort cancer cells so doctors can determine how well treatments are working.

March 19, 2013
Scientists Race to Stop the Spread of Deadly Superbugs

Infectious diseases specialist Kent Sepkowitz spoke about hospital-inquired infections, and how patients can be their own advocates to prevent them.

March 19, 2013
Getting Second Opinions after Cancer Diagnosis

Breast pathologist Edi Brogi and surgical oncologist Monica Morrow discussed when and how to get a second opinion to confirm a cancer diagnosis.

March 18, 2013
Mammogram Scares Leave Lasting Fears, Research Finds

Epidemiologist Talya Salz commented on a study that found that women experience significant stress when called for follow-up after a routine mammogram, and that the stress lasts long after follow-up tests show no signs of cancer.

March 18, 2013
Scientists ID Antibody That Might Boost Cancer Therapy

Physician-scientist David Scheinberg discussed his discovery of a unique monoclonal antibody, a molecule that can be engineered to target specific proteins on cancer cells. The new monoclonal antibody, called ESK1, is different because it is capable of recognizing the presence of a protein inside cancer cells, not just on the surface.

March 14, 2013
Sarcoma in the Young

Pediatric oncologist Paul Meyers discussed sarcomas, which affect more children and adolescents than adults.

March 13, 2013
How Caregivers Adjust to Post-Cancer Life

Clinical psychologist Allison J. Applebaum discussed the challenges caregivers experience when treatment ends.

March 13, 2013